Precision Medicine Market

1 Executive Summary

2 Introduction
     2.1 Study Objectives
          2.2 Market Definition
          2.2.1 Market Covered
          2.2.2. Geographical Coverage
          2.2.3. Study Years & Currency
     2.3. Market Stakeholders
     2.4. Key Questions this Study will Answer
     2.5. GMI Research’s Approach & Methodology

3 Global Precision Medicine Market – Overview
     3.1 Introduction
     3.2 Market Segmentation
     3.3 Value Chain Analysis
     3.5 Drivers
     3.6 Restraints
     3.7 Trends

4 Global Precision Medicine Market Revenue Forecast till 2025

5 Global Precision Medicine Market by Technology Revenue Forecast till 2025
     5.1. Big Data Analytics
     5.2. Gene Sequencing
     5.3. Companion Diagnostics
     5.4. Drug Discovery
     5.5. Bioinformatics

6 Global Precision Medicine Market by Application Revenue Forecast till 2025
     6.1. Oncology
     6.2. Neurology
     6.3. Immunology
     6.4. Respiratory
     6.5. Hematology
     6.6. Others

7 Global Precision Medicine Market by Geography Revenue Forecast till 2025
     7.1. North America Precision Medicine Market Revenue Forecast till 2025
          7.1.1. North America Precision Medicine Market by Type (Option 1: 25% customization)
                    7.1.1.1. Big Data Analytics
                    7.1.1.2. Gene Sequencing
                    7.1.1.3. Companion Diagnostics
                    7.1.1.4. Drug Discovery
                    7.1.1.5. Bioinformatics

          7.1.2. North America Precision Medicine Market by Application
                    7.1.2.1. Oncology
                    7.1.2.2. Neurology
                    7.1.2.3. Immunology
                    7.1.2.4. Respiratory
                    7.1.2.5. Hematology
                    7.1.2.6. Others

     7.2 Europe Precision Medicine Market Revenue Forecast till 2025
          7.2.1. Europe Precision Medicine Market by Type (Option 2: 25% customization)
                    7.2.1.1. Big Data Analytics
                    7.2.1.2. Gene Sequencing
                    7.2.1.3. Companion Diagnostics
                    7.2.1.4. Drug Discovery
                    7.2.1.5. Bioinformatics

          7.2.2. Europe Precision Medicine Market by Application
                    7.2.2.1. Oncology
                    7.2.2.2. Neurology
                    7.2.2.3. Immunology
                    7.2.2.4. Respiratory
                    7.2.2.5. Hematology
                    7.2.2.6. Others

     7.3 Asia-Pacific Precision Medicine Market Revenue Forecast till 2025
          7.3.1. Asia-Pacific Precision Medicine Market by Type (Option 3: 25% customization)
                    7.3.1.1. Big Data Analytics
                    7.3.1.2. Gene Sequencing
                    7.3.1.3. Companion Diagnostics
                    7.3.1.4. Drug Discovery
                    7.3.1.5. Bioinformatics

          7.3.2. Asia-Pacific Precision Medicine Market by Application
                    7.3.2.1. Oncology
                    7.3.2.2. Neurology
                    7.3.2.3. Immunology
                    7.3.2.4. Respiratory
                    7.3.2.5. Hematology
                    7.3.2.6. Others

     7.4 Rest of the World Precision Medicine Market Revenue Forecast till 2025
          7.4.1. Rest of the World Precision Medicine Market by Type (Option 4: 25% customization)
                    7.4.1.1. Big Data Analytics
                    7.4.1.2. Gene Sequencing
                    7.4.1.3. Companion Diagnostics
                    7.4.1.4. Drug Discovery
                    7.4.1.5. Bioinformatics

          7.4.2. Rest of the World Precision Medicine Market by Application
                    7.4.2.1. Oncology
                    7.4.2.2. Neurology
                    7.4.2.3. Immunology
                    7.4.2.4. Respiratory
                    7.4.2.5. Hematology
                    7.4.2.6. Others

8 Competitive Landscape
     8.1. Industry Attractiveness
          8.1.1. Porter’s Five Forces Analysis
     8.2. Major Players and Key Strategies

9 Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice)
     9.1. Abbott Laboratories
          9.1.1. Company Overview
          9.1.2. Financials
          9.1.3. Recent Developments

     9.2 bioMerieux SA
          9.2.1. Company Overview
          9.2.2. Financials
          9.2.3. Recent Developments

     9.3 Illumina, Inc.
          9.3.1. Company Overview
          9.3.2. Financials
          9.3.3. Recent Developments

     9.4 GE Healthcare
          9.4.1. Company Overview
          9.4.2. Financials
          9.4.3. Recent Developments

     9.5. Roche Group
          9.5.1. Company Overview
          9.5.2. Financials
          9.5.3. Recent Developments

     9.6. Nanostring Technologies
          9.6.1. Company Overview
          9.6.2. Financials
          9.6.3. Recent Developments

     9.7. IBM Corporation
          9.7.1. Company Overview
          9.7.2. Financials
          9.7.3. Recent Developments

     9.8. Thermo Fisher Scientific
          9.8.1. Company Overview
          9.8.2. Financials
          9.8.3. Recent Developments

     9.9. Novartis AG
          9.9.1. Company Overview
          9.9.2. Financials
          9.9.3. Recent Developments

     9.10. QIAGEN N.V
          9.10.1. Company Overview
          9.10.2. Financials
          9.10.3. Recent Developments

10 About GMI Research